Table 3 Distribution of baseline information by adverse clinical outcomes of COVID-19
Variables | ICU admission | P value | Death | P value | Disease severitya | P value | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Yes | No | Yes | No | Moderate | Severe | Critical | ||||
Age (years), mean ± SD | 56.64 ± 13.66 | 56.51 ± 15.24 | 0.923 | 62.38 ± 13.04 | 54.79 ± 14.80 | < 0.001 | 57.20 ± 15.46 | 54.39 ± 14.77 | 57.96 ± 13.07 | 0.084 |
Sex, n (%) | ||||||||||
Males | 108 (66.3) | 209 (58.1) | 0.075 | 78 (64.5) | 239 (59.5) | 0.323 | 141 (58.3) | 92 (59.4) | 84 (66.7) | 0.273 |
Females | 55 (33.7) | 151 (41.9) | 43 (35.5) | 163 (40.5) | 101 (41.7) | 63 (40.6) | 42 (33.3) | |||
CVDs, n (%) | ||||||||||
Yes | 79 (48.5) | 140 (38.9) | 0.040 | 58 (47.9) | 161 (40.0) | 0.123 | 98 (40.5) | 55 (35.5) | 66 (52.4) | 0.014 |
No | 84 (51.5) | 220 (61.1) | 63 (52.1) | 241 (60.0) | 144 (59.5) | 100 (64.5) | 60 (47.6) | |||
Asthma/COPD, n (%) | ||||||||||
Yes | 27 (16.6) | 25 (6.9) | 0.001 | 16 (13.2) | 36 (9.0) | 0.169 | 18 (7.4) | 9 (5.8) | 25 (19.8) | < 0.001 |
No | 136 (83.4) | 335 (93.1) | 105 (86.8) | 366 (91.0) | 224 (92.6) | 146 (94.2) | 101 (80.2) | |||
Diabetes, n (%) | ||||||||||
Yes | 52 (31.9) | 78 (21.7) | 0.012 | 35 (28.9) | 95 (23.6) | 0.237 | 34 (14.0) | 52 (33.5) | 44 (34.9) | < 0.001 |
No | 111 (68.1) | 282 (78.3) | 86 (71.1) | 307 (76.4) | 208 (86.0) | 103 (66.5) | 82 (65.1) | |||